Arnold S Monto Selected Research

Arnold S Monto Research Topics

Disease

119	Human Influenza (Influenza) 11/2022 - 03/2002
40	Infections 05/2022 - 03/2002
18	COVID-19 10/2022 - 01/2020
4	Pneumonia (Pneumonitis) 01/2022 - 11/2006
3	Disease Progression 10/2022 - 01/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 02/2003
2	Severe Acute Respiratory Syndrome 01/2021 - 09/2006
2	Frailty 01/2019 - 01/2019
2	Asthma (Bronchial Asthma) 01/2018 - 10/2012
2	Fever (Fevers) 01/2018 - 09/2006
2	Otitis Media 01/2018 - 11/2006
2	Cough 05/2016 - 09/2006
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Reinfection 01/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Sinusitis 01/2018
1	Pharyngitis (Sore Throat) 01/2018
1	Bronchitis 01/2018
1	Pregnancy Complications 01/2017
1	Nausea 05/2015
1	Vomiting 05/2015
1	Herpesviridae Infections (Herpesvirus Infection) 02/2014
1	Virus Diseases (Viral Diseases) 12/2013
1	Vaccine-Preventable Diseases 07/2013
1	Hepatitis A (Hepatitis, Infectious) 10/2007
1	Anthrax 09/2006
1	Communicable Diseases (Infectious Diseases) 09/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2003

Drug/Important Bio-Agent (IBA)

90	VaccinesIBA 10/2022 - 04/2005
58	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2022 - 08/2004
25	Antiviral Agents (Antivirals)IBA 11/2022 - 02/2003
13	Oseltamivir (Tamiflu)FDA Link 01/2018 - 08/2004
11	mRNA VaccinesIBA 10/2022 - 07/2021
11	AntibodiesIBA 01/2022 - 09/2010
11	Neuraminidase (Sialidase)IBA 05/2019 - 03/2002
8	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 09/2010
7	COVID-19 VaccinesIBA 10/2022 - 05/2021
7	Inactivated VaccinesIBA 01/2021 - 12/2006
7	Attenuated VaccinesIBA 10/2017 - 12/2006
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 01/2013
5	AntigensIBA 10/2017 - 08/2004
5	Zanamivir (Relenza)FDA Link 01/2007 - 12/2002
4	Pharmaceutical PreparationsIBA 11/2022 - 10/2008
4	Messenger RNA (mRNA)IBA 02/2022 - 11/2021
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 11/2006
3	BNT162 VaccineIBA 03/2022 - 11/2021
2	2019-nCoV Vaccine mRNA-1273IBA 03/2022 - 01/2022
2	EpitopesIBA 01/2022 - 01/2018
2	Biological ProductsIBA 01/2017 - 12/2013
2	EnzymesIBA 09/2006 - 07/2006
1	Ad26COVS1IBA 10/2022
1	Nucleic AcidsIBA 11/2021
1	Immunoglobulin G (IgG)IBA 09/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Combined VaccinesIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	CI 22IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018
1	cyclo(Arg-Pro) (CI 4)IBA 10/2016
1	Surface Antigens (Surface Antigen)IBA 12/2015
1	peramivirIBA 12/2014
1	Indicators and Reagents (Reagents)IBA 09/2010
1	LigandsIBA 09/2010
1	Immunoglobulins (Immunoglobulin)IBA 10/2007
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 10/2007
1	4-O-carboxymethylascochlorinIBA 11/2006
1	Amantadine (Aman)FDA LinkGeneric 11/2003
1	Prescription DrugsIBA 02/2003

Therapy/Procedure

5	Therapeutics 09/2014 - 03/2002
3	Ambulatory Care (Outpatient Care) 12/2020 - 09/2014
3	Hand Hygiene 07/2012 - 02/2010
2	Artificial Respiration (Mechanical Ventilation) 10/2022 - 11/2021
2	Home Nursing (Nursing, Home) 11/2006 - 08/2004
1	Critical Care (Surgical Intensive Care) 01/2022
1	Mechanical Ventilators (Ventilator) 12/2021
1	Length of Stay 12/2021
1	Medical Day Care (Partial Hospitalization) 10/2007
1	Patient Isolation 09/2006